Racial variation in adjuvant chemotherapy initiation among breast cancer patients receiving oncotype DX testing is a dataset published in UNC Libraries (2020). On theSindex it has a DataRank of 0.190, placing it in the top 65.6% of the data-sharing corpus. It has been cited 1 time, with 1 citing works in its 1-hop citation network.
Ranks in the top 66% for downstream scientific impact
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.104
From this paper's citation signal
Citation Network Contribution
0.0863
From 1 citing papers with measurable signal
Ranked by each citer's contribution to N(p) — log1p(Cq) divided by its reference count — out of 1 citer.
National Institutes of Health
Grant: 5UL1TR001111-05
North Carolina Translational & Clinical Sciences Institute (NC TraCS)
National Institutes of Health
Grant: 1R25CA057726-01
LINEBERGER CANCER CONTROL EDUCATION PROGRAM
National Institutes of Health
Grant: 5K12HD001441-12
UNC BIRCWH Career Development Program
National Institutes of Health
Grant: 5P50CA058223-12
SPORE in Breast Cancer
National Institutes of Health
Grant: 5K99HS022189-02
National Utilization Patterns of Oncotype DX in Early Stage Breast Cancer
FWCI
0.00
Citation Percentile
0.2%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals